MARKET

DMRA

DMRA

DAMORA THERAPEUT
NASDAQ
29.30
+0.13
+0.45%
Opening 12:49 07/24 EDT
OPEN
29.79
PREV CLOSE
29.17
HIGH
30.00
LOW
28.73
VOLUME
220.29K
TURNOVER
--
52 WEEK HIGH
38.33
52 WEEK LOW
2.450
MARKET CAP
1.80B
P/E (TTM)
-0.2072
1D
5D
1M
3M
1Y
5Y
1D
Analysts’ Top Healthcare Picks: Vertex Pharmaceuticals (VRTX), Valneva (VALN)
TipRanks · 2d ago
Analysts Are Bullish on These Healthcare Stocks: Damora Therapeutics (DMRA), Summit Therapeutics (SMMT)
TipRanks · 2d ago
Danaher Posts Q2 Results, Joins Calix, Equifax And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
Benzinga · 3d ago
Damora Therapeutics Completes Cayman Islands Redomestication
TipRanks · 3d ago
Weekly Report: what happened at DMRA last week (0713-0717)?
Weekly Report · 4d ago
Damora Therapeutics completes redomestication to the Cayman Islands
TipRanks · 07/17 12:20
Damora Therapeutics redomiciles from Delaware to Cayman Islands
PUBT · 07/17 12:02
Damora Announces Redomestication from Delaware to Cayman Islands
Barchart · 07/17 07:00
More
About DMRA
Damora Therapeutics Inc, formerly Galecto, Inc, is a clinical-stage biotechnology company focused on the development of novel treatments for cancer and liver diseases. The Company is engaged in the advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is significant medical need for disease-modifying treatments. It offers a multiple programs including asset, DMR-001, an investigational monoclonal antibody therapy targeting mutCALR. DMR-001 was designed to exclusively bind to mutCALR with exquisite selectivity, potency, and extended half-life, with potential to enable convenient, infrequent subcutaneous dosing.

Webull offers Damora Therapeutics Inc stock information, including NASDAQ: DMRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DMRA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DMRA stock methods without spending real money on the virtual paper trading platform.